AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
$AVXL Dr. Missling, just a heads-up for the Tuesda... See more
Jan, 12, 2023
As I mentioned, I wasn't expecting too much fr... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Jan, 6, 2023
Freshly approved drug and undervalued would mean t... See more
Dec, 29, 2022
Amazing positive news from the TGTX 20221229 confe... See more
RCAT
Red Cat Holdings Inc
-23.62%
$1.27 - $0.97
Feb 7th 2023 - Mar 21st 2023
Nov, 30, 2022
$RCAT I enjoyed the conference call and thought a... See more
Oct, 26, 2022
$RCAT nice PR and conference today.
Feb, 4, 2023
$AVXL Dr. Missling, just a heads-up for the Tuesday conference, investors will be comfortable holding the shares.
Jan, 12, 2023
As I mentioned, I wasn't expecting too much from this conference - seeing a 3% increase is great
Jan, 12, 2023
$AVXL love how seeking alpha article was published just before the conference. .nincompoops.
Jan, 12, 2023
$AVXL Great things will come out of this conference whether we know it today or not
Jan, 12, 2023
$AVXL Despite the fact that last year we expected the publication of the results of the RETT study at the JPM conference, they were not published and it was one of Missling's best performances all year.
Jan, 10, 2023
$AVXL $20S Good update/clarification of results prior/by JP Morgan conference can have this go straight to 50s.
Jan, 5, 2023
$AVXL GREAT NEWS within the next week for AVXL Anavex Life Sciences Corp. will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th 2023, at the Westin St. Francis in San Francisco, CA.
Jan, 2, 2023
$AVXL GREAT NEWS within the next 10 days for AVXL Anavex Life Sciences Corp. will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th 2023, at the Westin St. Francis in San Francisco, CA.
Dec, 5, 2022
$AVXL I just listen to the conference call with the professors wow wow wow !
Jan, 6, 2023
Freshly approved drug and undervalued would mean the JP conference should be ideal for us.
Dec, 29, 2022
Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.